Adrian Gabriel Torres PhD

Adrian Gabriel Torres holds a PhD and has a diverse work experience in the field of biochemistry and molecular biology. Adrian Gabriel is currently employed as the Head of Research and Development at Aptadel Therapeutics since June 2023. Prior to this, they worked as an Expert at BioExpert Network starting from August 2017.

Adrian's most extensive experience was at IRB Barcelona, where they held multiple roles. Adrian Gabriel served as a Research Associate from August 2020 to January 2023, leading the Gene Translation Lab. In this role, they focused on the dynamics of tRNAome (transfer RNA) in health and disease, developing tools to study tRNA gene expression and modification patterns. From October 2016 to August 2020, they worked as a Postdoctoral Researcher in the same lab, investigating the role of tRNA 'wobble' inosine in human physiology. This involved identifying genes and enzymes related to this modification and studying their activity and interactions.

Adrian also contributed to the scientific community as a PhD Supervisor at IRB Barcelona from February 2014 to December 2018. During this time, they mentored a PhD student in researching the role of tRNA modifications in the synthesis of the extracellular matrix. Additionally, they worked as a Postdoctoral Research Fellow in the Gene Translation Lab from October 2014 to October 2016, studying the evolutionary expansion of tRNA 'wobble' inosine in proteomes. Their research included analyzing tRNA gene content and enzyme activity across different organisms.

Before joining IRB Barcelona, Adrian gained valuable experience at MRC Laboratory of Molecular Biology (LMB) as a PhD Scholar from January 2009 to November 2011. In Dr. Michael Gait's Lab, they focused on microRNA targeting using synthetic oligonucleotide analogues. Adrian Gabriel evaluated various nucleic acid chemistries for antisense targeting of microRNAs and peptide-conjugated oligos.

Adrian's earliest work experience was as an Undergraduate Researcher in the Department of Biochemistry and Molecular Biology at Universidad Nacional de Córdoba from January 2006 to May 2007. There, they contributed to the molecular characterization of populations of Triatoma infestans, the primary vector of Chagas' disease in South America. Specifically, they analyzed variations in the mitochondrial 16S ribosomal RNA gene.

In summary, Adrian Gabriel Torres has a strong background in biochemistry and molecular biology, with expertise in tRNA dynamics, modifications, and their roles in health, disease, and evolution.

Adrian Gabriel Torres, PhD, has an extensive education history in the field of biology and business. In 2002, they started their academic journey at the Universidad Nacional de Córdoba, where they pursued a Bachelor's degree in Biology. Adrian Gabriel successfully completed their studies in 2007.

Building upon their undergraduate education, Torres went on to pursue a doctoral degree at the University of Cambridge. From 2008 to 2011, they dedicated their efforts to research and study in the field of Biology/Biological Sciences, eventually earning their Doctor of Philosophy (PhD) degree.

In recent years, Torres has shown a keen interest in business. In 2022, they attended workshops at Esade and IESE Business School, focusing on the intersection of science and business. At Esade, they participated in the workshop "From Science to Business," while at IESE Business School, they took part in the workshop "Science Meets Industry."

Overall, Adrian Gabriel Torres has a strong academic foundation, with a Bachelor's degree in Biology from the Universidad Nacional de Córdoba and a PhD in Biology/Biological Sciences from the University of Cambridge. Moreover, their recent engagement in business-related workshops underscores their desire to expand their knowledge and expertise in that field.